Effect of Lactobacillus fermentum on Beta2 Toxin Production by Clostridium perfringens

被引:28
作者
Allaart, Janneke G. [1 ]
van Asten, Alphons J. A. M. [1 ]
Vernooij, Johannes C. M. [2 ]
Grone, Andrea [1 ]
机构
[1] Univ Utrecht, Fac Vet Med, Dept Pathobiol, NL-3508 TD Utrecht, Netherlands
[2] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, NL-3508 TD Utrecht, Netherlands
关键词
EXPRESSION; BACTERIA; PH; DETERMINANTS; PREVALENCE; DISEASES; CACO-2; SYSTEM; HEALTH;
D O I
10.1128/AEM.03002-10
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
Clostridium perfringens, although a member of the normal gut flora, is also an important cause of intestinal disease in animals and, to a lesser extent, in humans. Disease is associated with the production of one or more toxins, and little is known about environmental influences on the production of these toxins. One of the health-promoting effects of lactic acid bacteria (LAB) is the establishment and maintenance of a low pH in the intestine since an acidic environment inhibits the growth of many potentially harmful bacteria. Here, the effect of the LAB Lactobacillus fermentum on beta2 toxin production by C. perfringens is described. Coculturing of C. perfringens with L. fermentum showed that under in vitro conditions, L. fermentum was capable of silencing beta2 toxin production by C. perfringens without influencing bacterial viability. The reduction in toxin production was shown to be most likely a result of the decline in pH. Quantitative PCR showed that the reduction in beta2 toxin production was due to a decrease in cpb2 mRNA. These results suggest that in the intestine, the production of beta2 toxin by C. perfringens might be regulated by other members of the normal intestinal flora.
引用
收藏
页码:4406 / 4411
页数:6
相关论文
共 34 条
[2]
The indigenous gastrointestinal microflora [J].
Berg, RD .
TRENDS IN MICROBIOLOGY, 1996, 4 (11) :430-435
[3]
Prevalence of cpb2, encoding beta2 toxin, in Clostridium perfringens field isolates:: correlation of genotype with phenotype [J].
Bueschel, DM ;
Jost, BH ;
Billington, SJ ;
Trinh, HT ;
Songer, JG .
VETERINARY MICROBIOLOGY, 2003, 94 (02) :121-129
[4]
Clostridium perfringens toxin genotypes in the feces of healthy North Americans [J].
Carman, Robert J. ;
Sayeed, Sameera ;
Li, Jihong ;
Genheimer, Christopher W. ;
Hiltonsmith, Megan F. ;
Wilkins, Tracy D. ;
McClane, Bruce A. .
ANAEROBE, 2008, 14 (02) :102-108
[5]
Importance of the host specificity in the selection of probiotic bacteria [J].
Dogi, Cecilia A. ;
Perdigon, Gabriela .
JOURNAL OF DAIRY RESEARCH, 2006, 73 (03) :357-366
[6]
Association of beta2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene [J].
Fisher, DJ ;
Miyamoto, K ;
Harrison, B ;
Akimoto, S ;
Sarker, MR ;
McClane, BA .
MOLECULAR MICROBIOLOGY, 2005, 56 (03) :747-762
[7]
Beta2 toxin, a novel toxin produced by Clostridium perfringens [J].
Gibert, M ;
Jolivet-Renaud, C ;
Popoff, MR .
GENE, 1997, 203 (01) :65-73
[8]
CHARACTERISTICS OF THE ADHESIVE DETERMINANTS OF LACTOBACILLUS-FERMENTUM-104 [J].
HENRIKSSON, A ;
SZEWZYK, R ;
CONWAY, PL .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1991, 57 (02) :499-502
[9]
Prevalence of β2-toxigenic Clostridium perfringens in horses with intestinal disorders [J].
Herholz, C ;
Miserez, R ;
Nicolet, J ;
Frey, J ;
Popoff, M ;
Gibert, M ;
Gerber, H ;
Straub, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (02) :358-361
[10]
Overview of gut flora and probiotics [J].
Holzapfel, WH ;
Haberer, P ;
Snel, J ;
Schillinger, U ;
Huis in't Veld, JHJ .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 1998, 41 (02) :85-101